{"nct_id":"NCT00774878","title":"Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer","status":"TERMINATED","status_verified_date":"2011-03","start_date":"2008-10","start_date_type":null,"primary_completion_date":"2010-11","primary_completion_date_type":"ACTUAL","completion_date":"2010-11","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["SNY"]}